Stanimir Vuk-Pavlovic

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi Dendritic cell microvilli: a novel membrane structure associated with the multifocal synapse and T-cell clustering
    Phyllis J Fisher
    Mayo Clinic, Rochester, MN, USA
    Blood 112:5037-45. 2008
  2. ncbi A Tribute to Dragan Primorac on the Twentieth Anniversary of The International Society of Applied Biological Sciences and Its Tenth Biennial Conference.
    Stanimir Vuk Pavlovi
    Stanimir Vuk Pavlovi, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA
    Croat Med J 58:201-202. 2017
  3. pmc Effects of oxygen on the antigenic landscape of prostate cancer cells
    Tangeng Ma
    Cancer Institute, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, USA
    BMC Res Notes 8:687. 2015
  4. doi Biomathematical modeling and cancer immunotherapy: report of the workshop held at Bol, Island of Brač, Croatia, 20-21 June 2011
    Stanimir Vuk-Pavlovic
    Mayo Clinic, Rochester, Minnesota, USA
    Cytotherapy 14:144-6. 2012
  5. pmc Rebuilding immunity in cancer patients
    Stanimir Vuk-Pavlovic
    Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Blood Cells Mol Dis 40:94-100. 2008
  6. pmc Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer
    Stanimir Vuk-Pavlovic
    Stem Cell Laboratory, Mayo Clinic Cancer Center, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Prostate 70:443-55. 2010
  7. ncbi Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo
    Allan B Dietz
    Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Blood 104:1094-9. 2004
  8. ncbi Immunomagnetic separation reagents as markers in electron microscopy
    Phyllis J Fisher
    Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St, S W, Rochester, MN 55905, USA
    J Immunol Methods 262:95-101. 2002
  9. ncbi A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers
    Allan B Dietz
    Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota 55095, USA
    Transfusion 46:2083-9. 2006
  10. ncbi Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial
    Patrick A Burch
    Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota 55902, USA
    Prostate 60:197-204. 2004

Collaborators

Detail Information

Publications16

  1. doi Dendritic cell microvilli: a novel membrane structure associated with the multifocal synapse and T-cell clustering
    Phyllis J Fisher
    Mayo Clinic, Rochester, MN, USA
    Blood 112:5037-45. 2008
    ..T cells preferentially bound to this site in clusters often contained both CD4(+) and CD8(+) T cells...
  2. ncbi A Tribute to Dragan Primorac on the Twentieth Anniversary of The International Society of Applied Biological Sciences and Its Tenth Biennial Conference.
    Stanimir Vuk Pavlovi
    Stanimir Vuk Pavlovi, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA
    Croat Med J 58:201-202. 2017
  3. pmc Effects of oxygen on the antigenic landscape of prostate cancer cells
    Tangeng Ma
    Cancer Institute, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, USA
    BMC Res Notes 8:687. 2015
    ..We hypothesized that cells grown in vitro at low oxygen tension (pO2) provide a better antigen match to tumors in situ and could reveal a more relevant antigenic landscape than cells grown in atmospheric pO2...
  4. doi Biomathematical modeling and cancer immunotherapy: report of the workshop held at Bol, Island of Brač, Croatia, 20-21 June 2011
    Stanimir Vuk-Pavlovic
    Mayo Clinic, Rochester, Minnesota, USA
    Cytotherapy 14:144-6. 2012
    ..Participants established a collaborative network to test some of the ideas discussed at the workshop and decided to review progress at the next meeting in Croatia in 2012...
  5. pmc Rebuilding immunity in cancer patients
    Stanimir Vuk-Pavlovic
    Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Blood Cells Mol Dis 40:94-100. 2008
    ..Thus, understanding and controlling these factors may appreciably impact the success of rebuilding and maintaining immunity in cancer patients...
  6. pmc Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer
    Stanimir Vuk-Pavlovic
    Stem Cell Laboratory, Mayo Clinic Cancer Center, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Prostate 70:443-55. 2010
    ..To determine if the levels of circulating myeloid-derived suppressor cells increase with progression of prostate cancer (PCa); to determine if such cells could contribute to the relative inefficiency of PCa immunotherapy...
  7. ncbi Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo
    Allan B Dietz
    Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Blood 104:1094-9. 2004
    ..These findings indicate that long-term administration of high-dose imatinib mesylate might affect immunity...
  8. ncbi Immunomagnetic separation reagents as markers in electron microscopy
    Phyllis J Fisher
    Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St, S W, Rochester, MN 55905, USA
    J Immunol Methods 262:95-101. 2002
    ..The large number of commercially available immunomagnetic reagents specific for different human, mouse and rat antigens provides additional resources for visualization of cellular ultrastructure...
  9. ncbi A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers
    Allan B Dietz
    Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota 55095, USA
    Transfusion 46:2083-9. 2006
    ..Buffy coats are becoming less available as a source of research-grade peripheral blood mononuclear cells (PBMNCs). Therefore, alternative sources of these cells were investigated...
  10. ncbi Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial
    Patrick A Burch
    Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota 55902, USA
    Prostate 60:197-204. 2004
    ..In this Phase 2 trial, we determined the efficacy of antigen presenting cells (APCs) loaded with PA2024, a recombinant fusion protein containing prostatic acid phosphatase (PAP) and GM-CSF...
  11. pmc Prognostic value of discs large homolog 7 transcript levels in prostate cancer
    Christian R Gomez
    Stem Cell Laboratory, Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, United States of America Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America Division of Preventive and Occupational Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
    PLoS ONE 8:e82833. 2013
    ....
  12. ncbi Modeling positive regulatory feedbacks in cell-cell interactions
    Zeljko Bajzer
    Biomathematics Resource Core, Department of Biochemistry and Molecular Biology, Mayo Clinic Cancer Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Biosystems 80:1-10. 2005
    ..In addition, we propose a perturbation approach to allow separation of cell-cell interactions dependent on the perturbing agent (such as hormone antagonists in hormone-dependent tissues) from cell-cell interactions independent of it...
  13. ncbi Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis
    Consuelo M López De Padilla
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Arthritis Rheum 56:1658-68. 2007
    ..To examine whether dendritic cells (DCs) are constituents of muscle inflammation in juvenile dermatomyositis (DM)...
  14. pmc Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma
    Svetomir N Markovic
    Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    J Transl Med 4:35. 2006
    ....
  15. pmc Age-dependent response of murine female bone marrow cells to hyperbaric oxygen
    Christian R Gomez
    Stem Cell Laboratory, Mayo Clinic Cancer Center, College of Medicine, Mayo Clinic, Rochester, MN, USA
    Biogerontology 13:287-97. 2012
    ..Our data demonstrate the impact of aging on the response of BM SCPs to HBO and indicate the potentially different age-related benefit of HBO in wound healing and tissue remodeling...
  16. pmc Malignant melanoma in the 21st century: the emerging molecular landscape
    Aleksandar Sekulic
    Department of Dermatology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Mayo Clin Proc 83:825-46. 2008
    ..We review the emerging molecular landscape of melanoma and its implications for better management of patients with melanoma...